CNN Money Digital Correspondent Paul La Monica discussed a few stocks and industries. Talking about the biotech market and the recent pullbacks, he said that, rather than a bubble, he sees many stocks with valuations that "don't seem to really be in line with reality particularly the smaller ones [which] are very volatile, and can move extremely dramatically, based on what's happening with clinical trials results."